New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
05:55 EDTAOL, AOL, ETR, ETR, LH, LH, MCO, MCOCompanies reporting Before the Market Open on Friday, February 8
Notable companies reporting before the opening bell on Friday include AOL (AOL), Entergy (ETR), Laboratory Corporation of America Holdings (LH), and Moodys (MCO).
News For AOL;ETR;LH;MCO From The Last 14 Days
Check below for free stories on AOL;ETR;LH;MCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 20, 2014
09:24 EDTAOLVringo intends to seek en banc review of decision in I/P Engine case
Vringo (VRNG) announced that its wholly-owned subsidiary I/P Engine, Inc. intends to file a petition with the United States Court of Appeals for the Federal Circuit seeking en banc review of the split appellate decision in its case against AOL (AOL), Google (GOOG) et al. that issued on August 15 and reversed the judgment of the United States District Court for the Eastern District of Virginia. Under the Federal Circuit's rules, I/P Engine's petition for en banc review is due on September 15. I/P Engine has filed an unopposed motion seeking a 30-day extension, which would make its petition due October 15. Upon receiving the requested extension, I/P Engine may file the petition on or anytime prior to October 15.
August 19, 2014
11:32 EDTLHLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
08:47 EDTLHLabCorp announces availability of InformaSeq non-invasive prenatal test
Laboratory Corporation of America Holdings announced the availability of the informaSeq Prenatal Test. The informaSeq Prenatal Test is an advanced, non-invasive, next-generation prenatal screening assay that can assess risk for multiple fetal chromosomal aneuploidies, or abnormalities in the number of chromosomes, from a single maternal blood draw. There are testing options for several additional common sex-related aneuploidies. The test is offered through Integrated Genetics, part of the LabCorp Specialty Testing Group of laboratories that offer advanced esoteric and genomic testing.
August 15, 2014
12:39 EDTAOLOn The Fly: Midday Wrap
Subscribe for More Information
11:45 EDTAOLVringo confirms adverse ruling in patent suit with Google, others
Subscribe for More Information
11:15 EDTAOLVringo falls after patent win against Google, AOL reversed on appeal
The U.S. Court of Appeals for the Federal Circuit that patents claims asserted by I/P Engine, a unit of Vringo (VRNG), are invalid for obviousness and reversed a lower court's ruling in the company's favor. The patents were asserted in a suit against Google (GOOG) and Aol (AOL), IAC Interactive (IACI) and Gannett (GCI). Vringo shares dropped nearly 11% following the posting of the appeal court ruling. Reference Link
07:19 EDTMCOSEC near finalizing new tougher rules for credit raters, WSJ says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use